Clinical Trials Browser

Endometrial Hyperplasia × semaglutide × 90 days × Clear all

NCT07462663 2026-05-13

SHAPE-ENDO

Phase 4 Not yet recruiting

GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight